Literature DB >> 17196903

Evaluation of the functional assessment of cancer therapy cognitive scale with hematopoietic stem cell transplant patients.

Sheri R Jacobs1, Paul B Jacobsen, Margaret Booth-Jones, Lynne I Wagner, Claudio Anasetti.   

Abstract

The current study evaluated a newly developed self-report measure of cognitive complaints with cancer patients, the Functional Assessment of Cancer Therapy Cognitive Scale (FACT-Cog). Six or 12 months following hematopoietic stem cell transplantation, participants completed a psychosocial assessment that included the FACT-Cog and a neuropsychological assessment. Using a criterion of two or more times a week, an average of 12 of a total of 50 items were endorsed as complaints on the FACT-Cog. FACT-Cog total, domain, and subscale scores were significantly correlated with measures of depression, fatigue, anxiety, and physical and mental well-being. FACT-Cog scores, with the exception of one subscale, Other People Noticed Deficits, were not significantly correlated with cognitive performance. In general, the FACT-Cog and a commonly used measure of cognitive complaints (European Organization for Research and Treatment of Cancer-Quality of Life Questionnaire-C30 Cognitive Functioning Scale) demonstrated similar psychometric properties. However, the FACT-Cog assesses broader aspects of cognitive complaints, thereby providing greater information about the types of cognitive complaints patients are experiencing.

Entities:  

Mesh:

Year:  2007        PMID: 17196903     DOI: 10.1016/j.jpainsymman.2006.06.011

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  44 in total

1.  The psychometric properties of the Korean version of the functional assessment of cancer therapy-cognitive (FACT-Cog) in Korean patients with breast cancer.

Authors:  Jin-Hee Park; Sun Hyoung Bae; Yong Sik Jung; Young-Mi Jung
Journal:  Support Care Cancer       Date:  2015-02-11       Impact factor: 3.603

Review 2.  A framework for assessment in oncology rehabilitation.

Authors:  Laura S Gilchrist; Mary Lou Galantino; Meredith Wampler; Victoria G Marchese; G Stephen Morris; Kirsten K Ness
Journal:  Phys Ther       Date:  2009-01-15

3.  A randomized trial of cognitive rehabilitation in cancer survivors.

Authors:  M M Cherrier; K Anderson; D David; C S Higano; H Gray; A Church; S L Willis
Journal:  Life Sci       Date:  2013-09-05       Impact factor: 5.037

4.  Tibetan sound meditation for cognitive dysfunction: results of a randomized controlled pilot trial.

Authors:  K Milbury; A Chaoul; K Biegler; T Wangyal; A Spelman; C A Meyers; B Arun; J L Palmer; J Taylor; L Cohen
Journal:  Psychooncology       Date:  2013-05-09       Impact factor: 3.894

Review 5.  Cognitive Effects of Chemotherapy and Cancer-Related Treatments in Older Adults.

Authors:  Jennifer N Vega; Julie Dumas; Paul A Newhouse
Journal:  Am J Geriatr Psychiatry       Date:  2017-04-06       Impact factor: 4.105

6.  A mixed methods analysis of perceived cognitive impairment in hematopoietic stem cell transplant survivors.

Authors:  Lisa M Wu; Nadia Kuprian; Krista Herbert; Ali Amidi; Jane Austin; Heiddis Valdimarsdottir; Christine Rini
Journal:  Palliat Support Care       Date:  2019-08

7.  Self-efficacy beliefs mediate the relationship between subjective cognitive functioning and physical and mental well-being after hematopoietic stem cell transplant.

Authors:  Lisa M Wu; Jane Austin; Jada G Hamilton; Heiddis Valdimarsdottir; Luis Isola; Scott Rowley; Rachel Warbet; Gary Winkel; William H Redd; Christine Rini
Journal:  Psychooncology       Date:  2011-07-08       Impact factor: 3.894

8.  A randomized trial comparing live and telemedicine deliveries of an imagery-based behavioral intervention for breast cancer survivors: reducing symptoms and barriers to care.

Authors:  Lyn W Freeman; Rebecca White; Chelsea G Ratcliff; Sue Sutton; Mary Stewart; J Lynn Palmer; Judith Link; Lorenzo Cohen
Journal:  Psychooncology       Date:  2014-08-22       Impact factor: 3.894

9.  Patient-Reported Cognitive Impairment Among Women With Early Breast Cancer Randomly Assigned to Endocrine Therapy Alone Versus Chemoendocrine Therapy: Results From TAILORx.

Authors:  Lynne I Wagner; Robert J Gray; Joseph A Sparano; Timothy J Whelan; Sofia F Garcia; Betina Yanez; Amye J Tevaarwerk; Ruth C Carlos; Kathy S Albain; John A Olson; Matthew P Goetz; Kathleen I Pritchard; Daniel F Hayes; Charles E Geyer; E Claire Dees; Worta J McCaskill-Stevens; Lori M Minasian; George W Sledge; David Cella
Journal:  J Clin Oncol       Date:  2020-04-09       Impact factor: 44.544

10.  Changes in neuronal activation patterns in response to androgen deprivation therapy: a pilot study.

Authors:  Monique M Cherrier; Paul R Borghesani; Amy L Shelton; Celestia S Higano
Journal:  BMC Cancer       Date:  2010-01-04       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.